4-(4-(3-(4-Chloro-3-(Trifluoromethyl)Phenyl)Ureido)Phenoxy)-N-(Methyl-D3)Picolinamide 4-(4-(3-(4-氯-3-(三氟甲基)苯基)脲基)苯氧基)-N-(甲基-d3)吡啶-2-甲酰胺

CAS 1130115-44-4 MFCD230115444

化学结构图

1130115-44-4
SMILES: [2H]C([2H])([2H])NC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1

化学属性

Mol. Weight467.8475
Mol. FormulaC21H13D3ClF3N4O3
Appearance Solid powder
SolubilitySoluble in DMSO, not in water

别名和识别编码

CAS Number1130115-44-4
Chemical Name4-(4-(3-(4-Chloro-3-(Trifluoromethyl)Phenyl)Ureido)Phenoxy)-N-(Methyl-D3)Picolinamide
Synonym 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-(methyl-d3)-2-pyridinecarboxamide Donafenib; CM-4307; CM 4307; CM4307.
Chemical Name Translation4-(4-(3-(4-氯-3-(三氟甲基)苯基)脲基)苯氧基)-N-(甲基-d3)吡啶-2-甲酰胺
FormulaC21H13D3ClF3N4O3
IUPAC Name4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-(methyl-d3)-2-pyridinecarboxamide
InChIKeyMLDQJTXFUGDVEO-FIBGUPNXSA-N
InChIInChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)/i1D3
Canonical SMILESO=C(C1=NC=CC(OC2=CC=C(NC(NC3=CC=C(Cl)C(C(F)(F)F)=C3)=O)C=C2)=C1)NC([2H])([2H])[2H]
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • Inhibitors
  • Isotope Labelled Compounds
  • Pharmaceuticals
  • Intermediates & Fine Chemicals,

产品应用

  • Donafenib, also known as CM-4307, is an oral multikinase inhibitor that targets Raf kinase and receptor tyrosine kinases with potential anticancer acivity. Donafenib is under clinical trials in China in patients with advanced hepatocellular carcinoma (HCC).

相关文献及参考

  • Richly, H., et al.: Int. J. Clin. Pharmacol. Ther., 41, 620 (2003),
  • Khire, U.R., et al.: Bioorg. Med. Chem. Lett., 14, 783 (2004),
  • Wilhelm, S.M., et al.: Cancer Res., 64, 7099 (2004),

安全信息

Storage condition Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

系列性分类


相关产品推荐